Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2018
January 15, 2019 at 03:51 am IST
Oramed Pharmaceuticals Inc. announced earnings results for the first quarter ended November 30, 2018. For the first quarter, the company announced sales was USD 674,000 compared to USD 611,000 a year ago. Operating income was USD 4.640 million compared to USD 2.732 million a year ago. Net loss was USD 4.302 million compared to USD 2.531 million a year ago. Basic earnings per share from continuing operations was USD 0.25 compared to USD 0.18 a year ago.